MRA Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
+23,652
New +$1.36M 0.49% 48
2025
Q1
Sell
-3,964
Closed -$224K 133
2024
Q4
$224K Sell
3,964
-621
-14% -$34.7K 0.12% 95
2024
Q3
$237K Sell
4,585
-1,303
-22% -$61.1K 0.13% 88
2024
Q2
$245K Buy
+5,888
New +$263K 0.14% 84
2023
Q3
Sell
-4,704
Closed -$301K 121
2023
Q2
$301K Buy
4,704
+15
+0.3% +$1.01K 0.21% 83
2023
Q1
$325K Buy
4,689
+1,723
+58% +$122K 0.23% 72
2022
Q4
$213K Buy
+2,966
New +$224K 0.17% 93
2021
Q3
Sell
-7,407
Closed -$495K 126
2021
Q2
$495K Sell
7,407
-558
-7% -$36.4K 0.42% 49
2021
Q1
$503K Buy
7,965
+898
+13% +$55.9K 0.47% 48
2020
Q4
$438K Buy
+7,067
New +$435K 0.43% 55

Other funds holding BMY